echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Science: Looking at cancer from the perspective of DNA

    Science: Looking at cancer from the perspective of DNA

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Proteins perform most of the functions in the human body, in various forms, far surpassing our genes, providing a broader perspective on the potential activity of cancer


    "We will discuss cancer from a single gene protein, let's see how we see patients with different mutations affect the same protein function," Ideker said, noting that this work represents the ability of new technology to explain the impact of mutations in a more precise way


    The effort to map these effects, called the Cancer Cellular Atlas Initiative (CCMI), has revealed the genetic patterns and organizational principles of this disease on a huge scale, as well as potential new ways to address it


    The team’s new research details this method and highlights its findings when used in breast and head and neck cancers


    From genetic mutation to protein destruction

    Our genes contain instructions to make proteins


    These gene mutations will affect the efficiency of the protein complex


    Ideker said that currently, doctors treat a small number of mutated genes as biomarkers — quantifiable indicators, such as the presence of specific molecules that indicate physical conditions — to help them determine whether a particular cancer drug may be beneficial to patients


    "The problem is that we only found a few genes, and we can use this method to help guide the prescription of FDA-approved drugs


    Mapped protein mutations

    Some genes in cancer are usually mutated, and each of these genes can be mutated in hundreds of different ways


    The goal of CCMI is to map the constellation of protein complexes composed of approximately 60 genes commonly associated with breast cancer or head and neck cancer, and to observe how each gene looks in healthy cells


    Doing so is a huge computational challenge


    "This kind of detail shows us how effective existing drugs may be, or explains why it doesn't work


    The authors say that the most powerful aspect of these broad protein interaction maps is that they can provide the same information in many other situations


    Ideker and Krogan believe that the CCMI collaboration is the real source of power behind this approach


    "We not only establish connections between different genes and proteins, but also establish connections between different people and different disciplines," Krogan said


    Krogan said: "We are in a perfect position to take advantage of this revolution on all levels



    Journal Reference :

    1. Danielle L.
      Swaney, Dana J.
      Ramms, Zhiyong Wang, Jisoo Park, Yusuke Goto, Margaret Soucheray, Neil Bhola, Kyumin Kim, Fan Zheng, Yan Zeng, Michael McGregor, Kari A.
      Herrington, Rachel O’Keefe, Nan Jin, Nathan K.
      VanLandingham, Helene Foussard, John Von Dollen, Mehdi Bouhaddou, David Jimenez-Morales, Kirsten Obernier, Jason F.
      Kreisberg, Minkyu Kim, Daniel E.
      Johnson, Natalia Jura, Jennifer R.
      Grandis, J.
      Silvio Gutkind, Trey Ideker, Nevan J.
      Krogan.
      A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity .
      Science , 2021; 374 (6563) DOI: 10.
      1126/science.
      abf2911


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.